These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2655687)

  • 1. A double-blind randomized cross-over study of the efficacy and tolerability of nifedipine and nitrendipine in the treatment of mild to moderate hypertension.
    Heagerty AM; Swales JD
    Br J Clin Pharmacol; 1989 Apr; 27(4):411-6. PubMed ID: 2655687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension.
    Maclean D; Mitchell ET; Lewis R; Irvine N; McLay JS; McEwen J; Coulson RR; Slater ND; Fitzsimons TJ; McDevitt DG
    Br J Clin Pharmacol; 1990 Apr; 29(4):455-63. PubMed ID: 2183868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety comparison of nitrendipine and hydralazine as antihypertensive monotherapy.
    Fagan TC; Sternleib C; Vlachakis N; Deedwania PC; Mehta JL
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1109-13. PubMed ID: 6085377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of felodipine and nifedipine as monotherapies for the treatment of mild to moderate hypertension.
    Abelardo NS; Ramos EF; Mendoza VL; Sulit YQ; Mitchell MJ
    J Hum Hypertens; 1989 Feb; 3(1):57-9. PubMed ID: 2657058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Felodipine versus prazosin as an addition to a beta-blocker in the treatment of essential hypertension. The Australian Multicentre Study.
    Jackson B; Morgan TO; Gibson J; Anderson A
    Drugs; 1987; 34 Suppl 3():109-19. PubMed ID: 2894971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Felodipine, a new calcium antagonist, as monotherapy in mild or moderate hypertension. Cooperative study group.
    Drugs; 1987; 34 Suppl 3():139-48. PubMed ID: 2894973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of nitrendipine combined with low-dose hydrochlorothiazide to hydrochlorothiazide alone in mild to moderate essential hypertension.
    Schoenberger JA; Glasser SP; Ram CV; McMahon SG; Vanov SK; Leibowitz DA
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1105-8. PubMed ID: 6085376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of hypertensive urgencies and emergencies with nitrendipine, nifedipine, and clonidine: effect on blood pressure and heart rate.
    Späh F; Grosser KD
    J Cardiovasc Pharmacol; 1988; 12 Suppl 4():S154-6. PubMed ID: 2468862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Felodipine in hypertensive patients. A dose finding study in patients refractory to beta-blocker monotherapy.
    Sluiter HE
    Drugs; 1987; 34 Suppl 3():97-106. PubMed ID: 2894980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose nitrendipine in mild hypertension: a double-blind, placebo-controlled, comparative study.
    Lederle RM; Klaus D; Wilk S; Knaup G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S48-50. PubMed ID: 1723455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiloride compared with nitrendipine in treatment of essential hypertension.
    Katzman PL; Henningsen NC; Hulthén UL
    J Hum Hypertens; 1988 Oct; 2(3):147-51. PubMed ID: 3236318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA; Drayer JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitrendipine vs. long-acting nifedipine in mild, moderate and severe hypertension.
    Guazzi MD; De Cesare N; Galli C; Tamborini G; Salvioni A
    Angiology; 1986 Jul; 37(7):508-18. PubMed ID: 2942062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrendipine efficacy and safety in patients with mild and moderate essential hypertension.
    Di Salvo MM; Finocchiaro PM; Bonaccorso M; Attanasio L
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S45-7. PubMed ID: 1723454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Once- and twice-daily nitrendipine in patients with hypertension and noninsulin-dependent diabetes.
    Fagan TC; Nelson EB; Lasseter KC; Crook J; Morledge J; Conrad KA
    Pharmacotherapy; 1986; 6(3):128-36. PubMed ID: 2942844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atenolol-nifedipine combinations compared to atenolol alone in hypertension: efficacy and tolerability.
    Maclean D; Mitchell ET; Coulson RR; Fitzsimons TJ; McDevitt DG
    Br J Clin Pharmacol; 1988 Apr; 25(4):425-31. PubMed ID: 3289598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study.
    Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH
    Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the effects of nitrendipine and enalapril in essential hypertension.
    Verkaaik R; Hogewind BL; Woittiez AJ
    J Cardiovasc Pharmacol; 1991; 18 Suppl 1():S63-6. PubMed ID: 1723460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone.
    Daniels AR; Opie LH
    Am J Cardiol; 1986 Apr; 57(11):965-70. PubMed ID: 3515899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrendipine and atenolol: comparison and combination in the treatment of arterial hypertension.
    de Divitiis O; Petitto M; Di Somma S; Galderisi M; Villari B; Santomauro M; Fazio S
    Arzneimittelforschung; 1985; 35(4):727-9. PubMed ID: 3160356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.